ABVC BioPharma Management
Management criteria checks 1/4
ABVC BioPharma's CEO is Uttam Patil, appointed in Jun 2023, has a tenure of less than a year. directly owns 0.69% of the company’s shares, worth $77.50K. The average tenure of the management team and the board of directors is 0.9 years and 5.3 years respectively.
Key information
Uttam Patil
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.7% |
Management average tenure | less than a year |
Board average tenure | 5.3yrs |
Recent management updates
Recent updates
ABVC BioPharma (NASDAQ:ABVC) Is Carrying A Fair Bit Of Debt
Mar 13Australian ethics committee approves ABVC's phase 2 study plan for its eye-gel substitute
Oct 05ABVC Biopharma rises on clinical update from Phase 2 trial of ADHD drug
Sep 23ABVC BioPharma (NASDAQ:ABVC) Has Debt But No Earnings; Should You Worry?
Aug 18ABVC BioPharma GAAP EPS of -$0.06 beats by $0.07, revenue of $0.31M beats by $0.3M
Aug 17ABVC Biopharma rises 18% on acceleration of ADHD drug Phase 2 trial
Jul 13Thai ethics committee approves ABVC's phase 2 study protocol for its eye-gel substitute
Jun 30Is ABVC BioPharma (NASDAQ:ABVC) Using Too Much Debt?
Apr 04Is ABVC BioPharma (NASDAQ:ABVC) A Risky Investment?
Dec 09Is ABVC BioPharma (NASDAQ:ABVC) A Risky Investment?
Aug 05CEO
Uttam Patil (37 yo)
less than a year
Tenure
Dr. Uttam Yashwant Patil, Ph D., is Chief Executive Officer of ABVC BioPharma, Inc. from June 21, 2023. Dr. Patil has served as the Chief Operating and Scientific Officer of the BioKey, Inc. since May 2023...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & Chief Business Officer | 8.8yrs | US$200.00k | 9.48% $ 1.1m | |
Chief Executive Officer | less than a year | no data | 0.69% $ 77.5k | |
CFO & Principal Accounting Officer | 1.7yrs | US$180.00k | 0.49% $ 55.6k | |
Chief Scientific Officer | less than a year | US$200.00k | 4.13% $ 465.0k |
0.9yrs
Average Tenure
37yo
Average Age
Experienced Management: ABVC's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & Chief Business Officer | 8.8yrs | US$200.00k | 9.48% $ 1.1m | |
Chief Scientific Officer | 5.3yrs | US$200.00k | 4.13% $ 465.0k | |
Director | 6.5yrs | no data | 0.40% $ 44.9k | |
Independent Director | 6.5yrs | no data | 0.40% $ 44.8k | |
Independent Director | 6.5yrs | no data | 0.40% $ 44.9k | |
Independent Director | 5.3yrs | no data | 0.55% $ 61.8k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Director | 6.5yrs | no data | 0.40% $ 44.8k | |
Independent Director | 2yrs | no data | 0.40% $ 44.6k | |
Director | 2yrs | no data | 8.28% $ 933.6k | |
Independent Director | 1.9yrs | no data | 0.46% $ 51.4k | |
Independent Director | 1.8yrs | no data | 0.40% $ 44.9k |
5.3yrs
Average Tenure
58yo
Average Age
Experienced Board: ABVC's board of directors are considered experienced (5.3 years average tenure).